- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT06894043
Effekt af et interventionsprogram med tilpasset fysisk aktivitet kombineret med kompenserende ernæring hos patienter med forfatningsmæssig tyndhed (ANIMATION)
Constitutional Thinness (CT) is a form of stable thinness without malnutrition but with resistance to weight gain, affecting approximately 1% of the general population. The clinical consequences are numerous and the pathophysiology remains poorly understood.
Currently, conventional management involves a high-calorie and frequent diet, combined with the avoidance of endurance physical activity, although there is no significant evidence of its effectiveness.
Our hypothesis is that an adapted physical activity program (APA) combined with compensatory nutrition (CN) could help these patients gain lean mass (muscle mass).
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Natacha GERMAIN, PhD
- Telefonnummer: +33 (0)477120621
- E-mail: natacha.germain@chu-st-etienne.fr
Undersøgelse Kontakt Backup
- Navn: Florence RANCON, Cheffe de projet
- Telefonnummer: +33 (0) 477829458
- E-mail: florence.rancon@chu-st-etienne.fr
Studiesteder
-
-
France
-
Saint-Etienne, France, Frankrig, 42055
- Rekruttering
- CHU de Saint-Etienne
-
Kontakt:
- Natacha GERMAIN, PhD
- Telefonnummer: +33 (0)477120621
- E-mail: natacha.germain@chu-st-etienne.fr
-
Kontakt:
- Florence RANCON, Cheffe de projet
- Telefonnummer: +33 (0) 477829458
- E-mail: florence.rancon@chu-st-etienne.fr
-
Underforsker:
- Bogdan GALUSCA, PhD
-
Underforsker:
- David HUPIN, PhD
-
Underforsker:
- Leonard FEASSON, PhD
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Gender: Female
- BMI: ≤ 18.5 kg/m²
- Weight Stability: Stable weight for at least 3 months
- Age: 18 to 50 years old at the inclusion visit
- Diagnosed with Constitutional thinness
Exclusion Criteria:
- Pregnancy, Parturition, or Lactation
- Legal Restrictions: Individuals deprived of liberty, involuntarily hospitalized, or hospitalized for reasons other than research purposes, adults under legal protection (guardianship or curatorship) or unable to provide consent
- Eating Disorders: Individuals with eating disorders (DSM IV and 5 criteria)
- Excessive Alcohol Consumption: Consumption exceeding the equivalent of 10 glasses of wine per week
- Severe Progressive Conditions: Progressive severe conditions (e.g., diabetes)
- Intense Physical Activity: Individuals engaging in intense physical activity (> 3 sessions per week)
- Heavy Smoking: Significant smoking (>10 cigarettes per day)
- Psychiatric Conditions: Presence of depressive or psychiatric conditions requiring antidepressant or psychotropic treatment
- Medical or Surgical History: Medical or surgical history deemed incompatible with the study by the investigator
- MRI Contraindication: Individuals with contraindications to MRI will not undergo spectro-MRI analyses
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: APA + NC
|
The APA intervention will consist of a 2-week running-in period, followed by a period of adapted physical activity (APA) for 8 weeks. The Compensatory Nutrition (NC) intervention will consist of a 2-week running-in period, followed by a period of compensated nutrition (NC) for 8 weeks. |
|
Ingen indgriben: Control
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Lean body mass
Tidsramme: From day 1 to week 8
|
Lean body mass gain (kg) measured by bioimpedance |
From day 1 to week 8
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
BMI
Tidsramme: From day 1 to week 8
|
Body masse index : ratio between weight and height |
From day 1 to week 8
|
|
Energy balance
Tidsramme: From day 1 to week 8
|
Ratio between calorie intake and calorie expenditure Caloric intake measured by dietary records over 2 weeks (calorie); Calorie expenditure: Resting metabolism measured by indirect calorimetry (kcal/24h); + Postprandial thermogenesis measured by indirect calorimetry (kcal/24h);; + Physical activity energy expenditure measured by connected watch (kcal/24h); |
From day 1 to week 8
|
|
Physical exercise capacity
Tidsramme: From day 1 to week 8
|
Changes in VO2max |
From day 1 to week 8
|
|
Quality of life SF-12 questionnaire
Tidsramme: From day 1 to week 8
|
SF-12 questionnaire; Self-measurement questionnaire SF-12 (Short Form Health Survey 12); comprising 12 questions assessing 8 dimensions, namely physical functioning, role limitation due to physical problems, role limitation resulting from emotional problems, vitality (energy/fatigue), emotional well-being, social functioning, bodily pain, and perception of general and mental health; each dimension is represented by a score ranging from 0 to 100, with a low score signifying poor health perception in the dimension considered, and a high score signifying the opposite); |
From day 1 to week 8
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- 24CH263
- ANSM (Anden identifikator: 2025-A00088-41)
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .